Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like ...

UCB, a global biopharmaceutical company, announced today that a single-injection 2 mL prefilled syringe and autoinjector, each containing 320 mg of ...

Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on data from 2 phase 3 trials: BE OPTIMAL and BE COMPLETE.

For example, RA may cause scarring on the lungs that makes it hard to breathe. Psoriatic arthritis (PsA) is an inflammatory disease that affects your joints and skin. The major joints affected by ...

Your provider may check for symptoms of psoriasis to determine if you have psoriatic arthritis. Signs of psoriasis often appear on the skin first before joint symptoms begin and include: You may also ...

Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching among patients with psoriasis ...

Your feet can tell you a lot about your general health condition or warn you of underlying health conditions. From pesky foot ...

UCB’s 320 mg/2 mL prefilled syringe and autoinjector for single-injection administration option is available now in US: Brussels, Belgium Saturday, January 18, 2025, 16:00 Hrs [ ...

Conclusions Apremilast was effective in the treatment of psoriatic arthritis, improving signs and symptoms and physical function. Apremilast demonstrated an acceptable safety profile and was generally ...

Perioral dermatitis is a rash that appears as clusters of inflamed skin and small raised bumps around the mouth and nose. The ...

Psoriatic arthritis (PsA) is a complex ... In particular, as discussed above, physical activity may reduce both articular and extra-articular signs and symptoms and even systemic inflammation.